New Hyde Park, NYNCT07369063Now EnrollingIRB Ready

Graves Disease Clinical Trial in New Hyde Park, NY

Access cutting-edge graves disease treatment through this phase 2 clinical trial at a research site in New Hyde Park. Study-provided care at no cost to qualified participants.

Sponsored by Northwell Health

Quick Self-Assessment

See if you qualify for this New Hyde Park location

Preparing your pre-screening questions…

Expert Care in New Hyde Park

Access graves disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related graves disease treatment provided free

Apply for This New Hyde Park Location

Check if you qualify for this graves disease clinical trial in New Hyde Park, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Hyde Park

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Hyde Park site if eligible
  4. 4Begin participation

About This Graves Disease Study in New Hyde Park

The goal of this randomized pilot feasibility clinical trial is to determine the feasibility of implementing a protocol for a larger trial to assess the effects of high-dose vitamin D supplementation in pediatric patients (9-17 years old) newly diagnosed with Graves' disease. The main questions it aims to answer are: What are the recruitment and adherence rates for a larger trial using this protocol? Is the data collection process complete and robust enough for a larger trial? What are the potential barriers to implementing a larger-scale trial? Researchers will compare vitamin D supplementation plus standard methimazole therapy to methimazole therapy alone (with participants permitted to take up to 1000 International Units of vitamin D2 daily) to explore potential effects on thyroid hormone and antibody levels. Participants will: Be randomized to either the intervention or control group. Take study medications (vitamin D or placebo) as directed. Attend regular study visits for blood tests and clinical assessments. Complete medication logs.

Sponsor: Northwell Health

Who Can Participate

Inclusion Criteria

All new pediatric participants aged 9-17 years with a new diagnosis of GD who will be started on methimazole, will be offered to participate at the time of diagnosis.
Biochemical features include:
Suppressed TSH \<0.1.
Elevated T3
Elevated Free T4
Elevated T4
Positive TSI or TRAb. The presence of antibodies is diagnostic.
Our study will offer enrollment to non-English speaking participants

Exclusion Criteria

Initial hydroxy vitamin D levels \>80 ng/mL
Hypocalcemia, corrected calcium based on albumin \<8.4 mg/dL
Hypercalcemia, corrected calcium based on albumin \>10.5 mg/dL
Conditions that affect vitamin D metabolism such as: malabsorption, chronic kidney or liver disease, nephrocalcinosis, hyperparathyroidism
Current use of medications which are known to affect thyroid function or vitamin D metabolism such as thyroid hormone replacement, corticosteroids, anticonvulsants
Allergy to vitamin D or methimazole
Diagnosis of Hashitoxicosis or thyrotoxicosis (both TSH receptor antibody (TRAb) and thyroid-stimulating immunoglobulin (TSI) levels are negative)
Participants under the age of 9 years at the time of diagnosis
Pregnant participants
Active or uncontrolled infections, other significant medical conditions deemed by the investigator to interfere with study participation or pose undue risk to the participant.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Hyde Park?

Yes, this clinical trial (NCT07369063) has an active research site in New Hyde Park, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Graves Disease Treatment Options in New Hyde Park, NY

If you're searching for graves disease treatment options in New Hyde Park, NY, this clinical trial (NCT07369063) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Hyde Park research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced graves disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all graves disease clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in New Hyde Park, NY

See all rheumatoid arthritis clinical trials recruiting in New Hyde Park — not just this study.

Browse Rheumatoid Arthritis Trials in New Hyde Park →

Ready to Join in New Hyde Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Hyde Park, NY